+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: Relation between exercise hyperemia and endothelial function



Endothelial dysfunction and decreased exercise tolerance in interferon-alpha therapy in chronic hepatitis C: Relation between exercise hyperemia and endothelial function



Clinical Cardiology 24(4): 286-290



Background: We previously reported that reversible endothelial dysfunction is caused by interferon-alpha therapy (IFN) in patients with chronic hepatitis C. In experimental studies, limb blood flow during exercise is reported to be dependent on endothelium-derived nitric oxide. Hypothesis: The purpose of this study was to confirm the effect of IFN on endothelial function and to investigate whether exercise hyperemia is dependent on endothelial function in humans. Methods: We performed symptom-limited exercise treadmill testing and measured flow-mediated vasodilation (FMD, endothelium-dependent vasodilation) and sublingual glyceryl-trinitrate-induced dilation (GTN-D, 0.3 mg, endothelium-independent vasodilation) in the brachial artery by using high-resolution ultrasound in 10 patients with chronic active hepatitis C (age 53 +- 11 years, 2 men, 8 women) before and immediately after administration of recombinant interferon 2b (10 million U/day) for 4 weeks. Results: There were no significant abnormal findings in any patients in routine studies of 24-h ambulatory electrocardiogram monitoring, two-dimensional echocardiography, and exercise treadmill testing both before and after treatment. Leg fatigue and exhaustion were the reasons for termination of exercise treadmill testing in each patient. Pressure rate product was calculated at rest and peak exercise. Interferon-alpha therapy significantly (p<0.05) decreased FMD (6.8 +- 3.1 vs. 1.9 +- 2.6%), exercise treadmill testing tolerance time (437 +- 89 vs. 395 +- 62 s) and peak pressure rate product (283 +- 41 vs. 241 +- 47 mmHg cntdot beats/min cntdot 10-2), but not GTN-D (13.4 +- 5.4 vs. 17.0 +- 5.5%). The change of FMD due to IFN significantly and highly correlated with exercise treadmill testing tolerance time (r = 0.86, p<0.001), but not with change of peak pressure rate product, suggesting that FMD is more closely related to the condition of the peripheral circulation than is cardiac performance. Conclusion: These results suggest that IFN in patients with chronic hepatitis C impairs endothelial function and exercise tolerance, and that endothelial function might be at least partly involved in exercise hyperemia in humans.

(PDF emailed within 0-6 h: $19.90)

Accession: 010585872

Download citation: RISBibTeXText

PMID: 11303695

DOI: 10.1002/clc.4960240406


Related references

Exercise hyperemia is dependent on endothelial function Clinical evidence from interferon-induced endothelial dysfunction in humans. Journal of the American College of Cardiology 33(2 SUPPL A): 550A-551A, 1999

Reversible endothelial dysfunction caused by interferon alpha therapy in chronic hepatitis C patients. Circulation 96(8 SUPPL ): I728, 10/21/97, 1997

Relation of serial changes in endothelial function, exercise ischemic parameters, and blood markers in subjects with stable angina undergoing aggressive lipid-lowering The Can-ADA endothelial dysfunction substudy. Circulation 104(17 Supplement): II 446, October 23, 2001

Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure. Circulation 98(24): 2709-2715, 1998

Genetic components of exercise tolerance, endothelial and autonomic function and their changes by exercise training in patients with coronary artery disease. European Heart Journal 34(Suppl 1): P5789-P5789, 2013

Pulmonary factors and endothelial dysfunction determine exercise tolerance and extent of dyspnea in patients with chronic heart failure. European Heart Journal 21(Abstract Supplement): 660, August-September, 2000

Chronic heart failure and aging - effects of exercise training on endothelial function and mechanisms of endothelial regeneration: Results from the Leipzig Exercise Intervention in Chronic heart failure and Aging (LEICA) study. European Journal of Preventive Cardiology 23(4): 349-358, 2016

Relation Between Endothelial Microparticles and Endothelial Function Following Acute Exercise in Men with CAD. Medicine & Science in Sports & Exercise 43(Suppl 1): 735-736, 2011

Endothelial cell senescence with aging in healthy humans: prevention by habitual exercise and relation to vascular endothelial function. American Journal of Physiology. Heart and Circulatory Physiology 313(5): H890-H895, 2017

Nebivolol therapy improves endothelial function and increases exercise tolerance in patients with cardiac syndrome X. Anadolu Kardiyoloji Dergisi 9(5): 371-379, 2010

Effect of repeated sauna treatment on exercise tolerance and endothelial function in patients with chronic heart failure. American Journal of Cardiology 109(1): 100-104, 2012

Recombinant interferon alpha treatment decreases heart rate variability indices and impairs exercise tolerance in patients with chronic hepatitis. Biomedicine & PharmacoTherapy 59 Suppl 1: S163-S168, 2005

Worsening of left ventricular diastolic dysfunction during exercise causes decreased exercise tolerance in hypertension. Clinical Cardiology 23(9): 660-664, 2000

Interferon- and ribavirin-free therapy with new direct acting antivirals (DAA) for chronic hepatitis C improves vascular endothelial function. International Journal of Cardiology 271: 296-300, 2018

Hemosiderin deposition in portal endothelial cells is a histologic marker predicting poor response to interferon-alpha therapy in chronic hepatitis. Pathology International 47(6): 347-352, 1997